- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Less than two years later, Alexion is not getting the bang for the mega-bucks it put up for Synageva.
Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.
Fed Chair Janet Yellen will give her two-day semiannual monetary policy testimony, while major economic data will drive markets.